Abbonarsi

Machine learning models based on a national-scale cohort accurately identify patients at high risk of deep vein thrombosis following primary total hip arthroplasty - 03/06/25

Doi : 10.1016/j.otsr.2025.104238 
Ziwei Huang, Anirudh Buddhiraju, Tony Lin-Wei Chen, MohammadAmin RezazadehSaatlou, Shane Fei Chen, Blake M. Bacevich, Pengwei Xiao, Young-Min Kwon
 Bioengineering Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, United States 

Corresponding author at: Department of Orthopaedic Surgery, Massachusetts General Hospital, Harvard Medical School, 55 Fruit Street, Boston 02114, MA, United States.Department of Orthopaedic SurgeryMassachusetts General HospitalHarvard Medical School55 Fruit StreetBostonMA02114United States

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

The occurrence of deep venous thrombosis (DVT) following total hip arthroplasty (THA) poses a substantial risk of morbidity and mortality, highlighting the need for preoperative risk stratification and prophylaxis initiatives. However, there exists a paucity of big-data-driven predictive models for DVT risk following elective hip arthroplasty. Therefore, this study aimed to develop and assess machine learning (ML) models in predicting DVT risk following THA using a national patient cohort.

Hypothesis

We hypothesized that machine learning models would accurately predict patient-specific DVT risk in patients undergoing elective total hip arthroplasty.

Patients and methods

The ACS-NSQIP national database was queried to identify 70,733 THA patients from 2013 to 2020, including 317 patients (0.45%) with DVT. Artificial neural network, random forest, histogram-based gradient boosting, k-nearest neighbor, and support vector machine algorithms were trained and utilized to predict the risk of DVT following THA. Model performance was assessed using discrimination, calibration, and potential clinical utility.

Results

Histogram-based gradient boosting demonstrated the best prediction performance with an area under the receiver operating curve of 0.93 (discrimination), a slope of 0.92 (closely aligned with actual outcomes), an intercept of 0.18 (minimal prediction bias), and a Brier score of 0.010 (high accuracy). The model also demonstrated clinical utility with greater net benefit than alternative decision criteria in the decision curve analysis. Length of stay, international normalized ratio, age, and partial thromboplastin time were the strongest predictors of DVT after primary THA.

Discussion

Machine learning models demonstrated excellent predictive performance in terms of discrimination, calibration, and decision curve analysis. Further research is warranted in terms of external validation to realize the potential of these algorithms as a valuable adjunct tool for risk stratification in patients undergoing THA.

Level of evidence

III; Retrospective study.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Machine learning, Total hip arthroplasty, Deep vein thrombosis, Artificial intelligence, Clinical decision support, Venous thromboembolism


Mappa


© 2025  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 111 - N° 4

Articolo 104238- giugno 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Sagittal alignment of the spine and lumbar disc herniation in young adults: A historical, case-control study
  • Mourad Ould-Slimane, François-Xavier Ferracci, André Gillibert, Marc Szadkowski, Caroline Lesage, Thais Dutra Vieira, Riccardo Sacco, Henri d’Astorg
| Articolo seguente Articolo seguente
  • What is the lower limb length discrepancy after arthroplasty for proximal femoral fracture? A prospective, multicenter observational study of 590 hips
  • Fredson Razanabola, Henri-Antoine Peuchot, Roger Erivan, Xavier Flecher, Marie Pierret, Hervé Nieto, Christophe Chantelot, Mehdi Hormi-Menard, Benoît Villain, Pierre Martz, François Loubignac, Olivier Gastaud, Régis Bernard de Dompsure, Anthony Viste, Philippe Boisrenoult, Erwan Pansard, Pierre Klein, Romain Rey, Alain Duhamel, Henri Migaud, SoFCOT

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.